AI
Friday, September 22, 2023 3:51:22 PM
Takeaways:
* Total Market at All-Time-High (181,403, Slide #2)
* VASCEPA narrowing the gap with generic Lovaza (Slide #1)
* All products up for the week, VASCEPA leads the pack with 14.47% increase (+8264)! (Slide#3)
* VASCEPA increases market share vs. generic VASCEPA (58.02% vs. 41.92%, Slide#4)
* Q3 will top Q2 in total scripts (Slide#5)
* September is on track to be VASCEPA's best month (Slide#6)
Recent AMRN News
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
